NCT03276832 2026-03-19
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
Clinical Trials
70 trialsNCT07210775 2026-03-04
Topical Imiquimod Treatment of Oral Dysplasia
University of Southern California
Phase 1/2 Recruiting
NCT01795313 2026-02-05
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
University of Pittsburgh
Phase 1 Terminated
NCT02600949 2026-01-29
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03534947 2025-12-16
SONIB
Melanoma Institute Australia
Phase 2 Completed
NCT04808245 2025-09-22
INTERCEPT-H3
German Cancer Research Center
Phase 1 Active not recruiting
NCT04883645 2025-01-28
Neoadjuvant Imiquimod Immunotherapy for Oral Cancer
Medical University of South Carolina
Phase EARLY_PHASE1 Completed
NCT06686043 2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2 Recruiting
NCT04809662 2024-11-07
Comparing Immune Responses to Topical Imiquimod
University of California, Davis
Terminated
NCT01803152 2024-07-03
Dendritic Cell Vaccine for Children and Adults With Sarcoma
University of Miami
Phase 1 Completed
NCT02394132 2024-06-20
RADICAL
Melanoma and Skin Cancer Trials Limited
Phase 3 Completed
NCT00799110 2024-06-11
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
Beth Israel Deaconess Medical Center
Phase 2 Active not recruiting
NCT02864147 2024-05-02
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Phase 2 Completed
NCT06252857 2024-05-01
REDT-BCC
Maastricht University Medical Center
Recruiting
NCT05838599 2024-03-12
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
Northwestern University
Phase EARLY_PHASE1 Unknown
NCT03559413 2023-12-04
Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL
University Children's Hospital Tuebingen
Phase 1/2 Completed
NCT05405270 2023-09-11
PRedICT-TOPIC
Catharina Ziekenhuis Eindhoven
Recruiting
NCT00788164 2023-08-31
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00314756 2023-08-22
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
Wake Forest University Health Sciences
Phase 4 Completed
NCT05740969 2023-02-23
PACKS
Zealand University Hospital
Phase 2 Unknown
NCT02802943 2022-11-28
iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL
University Hospital Tuebingen
Phase 2 Completed
NCT00142454 2022-10-10
NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
Ludwig Institute for Cancer Research
Phase 1 Completed
NCT01808820 2022-07-20
Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
University of Miami
Phase 1 Completed
NCT04842422 2022-01-11
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
Medical University of Graz
Phase 4 Completed
NCT01421017 2021-11-18
Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
NYU Langone Health
Phase 1/2 Completed
NCT03982004 2021-06-21
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Washington University School of Medicine
Phase 1 Terminated
NCT04859361 2021-05-03
Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ
University Medical Centre Maribor
Phase NA Unknown
NCT01861535 2021-04-14
PITVIN
Medical University of Graz
Phase 3 Completed
NCT03233412 2021-02-17
Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions
Barretos Cancer Hospital
Phase 2 Completed
NCT03914417 2021-01-20
Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT03289260 2020-09-23
AdAM
Medical University Innsbruck
Phase 3 Unknown
NCT04072900 2020-04-28
A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
Xiangya Hospital of Central South University
Phase 1 Unknown
NCT00118313 2020-03-27
Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
University of Virginia
Phase 1 Completed
NCT01400672 2020-03-18
Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated
NCT01678352 2020-02-24
Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT02385188 2020-01-02
Topical 5% Imiquimod Cream for Vulvar Paget's Disease
University Medical Center Nijmegen
Phase 3 Completed
NCT02276300 2019-11-20
HER2
Technical University of Munich
Phase 1 Completed
NCT01088737 2019-08-13
Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
Medical University of Graz
Phase 2/3 Unknown
NCT01191034 2019-03-12
Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1/2 Terminated
NCT00814528 2018-09-10
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
University of Chicago
Phase NA Withdrawn
NCT02917746 2018-08-16
TOPIC-3
Maastricht University Medical Center
Phase NA Unknown
NCT02329171 2018-08-15
TOPIC
Maastricht University Medical Center
Phase 3 Terminated
NCT00988559 2018-07-09
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00504023 2018-06-06
Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00979550 2018-03-22
The Effects of Aldara as an Adjunct to Laser Treatment
University of Kentucky
Phase 2 Terminated
NCT02669459 2018-02-06
TopIC-2
Erasmus Medical Center
Phase 3 Unknown
NCT00821964 2018-01-02
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
University of Washington
Phase 2 Completed
NCT01171469 2017-12-02
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT02281682 2017-10-30
Akti
Maastricht University Medical Center
Phase 4 Unknown
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated